Hizentra 20% subcutaneous injection 2g/10mL syringe (YJ code: 6343439G2023, 2g 10mL 1 tube), manufactured by CSL Behring, contains pH4 treated acidic human immunoglobulin (subcutaneous injection). It is used for the treatment of primary immunodeficiency (PI) and for maintenance therapy in adults with chronic inflammatory demyelinating polyneuropathy (CIDP).
Hizentra 20% subcutaneous injection 2g/10mL syringe
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →